The content you are trying to access is intended
for healthcare professionals only. 


Are you a healthcare professional?
The content you are about to view is intended for consumers. You are being redirected.
The content you are about to view is intended for healthcare professionals. You are being redirected.

Resources for Fat Metabolism

These materials have been developed in conjunction with Key Opinion Leaders (KOLs) and healthcare professionals, to enhance your learning and knowledge.
Programs for Continuing Professional Education (CPE)
The Therapeutic Role of Medium Chain Triglycerides

Speaker: ​Evan Berk, PhD, Global R&D Lead, Metabolic Health, Nestle Health Science

This program was recorded on ​October 30, 2019

Learning Objectives:

  1. Gain an understanding of what are medium chain triglycerides
  2. Historical uses of MCTs as a therapeutic agent in disease management
  3. Emerging and novel application of MCT for disease management

 

RDs and DTRs practicing in the US may log CPE activities under Activity Type 175 for up to three years from the original presentation date. This program is eligible for 1 CPEU. The activity number for viewing the recording through October 30, 2022 is 152215 (level 1,2,3).

Vitaflo will not provide a CE certificate for this activity. We encourage individuals to follow CDR guidance: Documentation to Retain: Print-out of hosting website. Please print this page for your records. To learn more about submitting this activity type visit CDR.

The Therapeutic Role of Medium Chain Triglycerides Edited from Vitaflo USA.

Product Resources